Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Addiction Medicine
Study results from Karolinska University, Karolinska Institute in the area of addiction medicine published
April 13th, 2008
New research, 'HPLC evaluation of clinical and pharmacological factors reported to cause false-positive carbohydrate-deficient transferrin (CDT) levels,' is the subject of a report. According to recent research published in the journal Clinica Chimica Acta, "Carbohydrate-deficient transferrin (CDT) is an alcohol biomarker used for detection and follow-up of excessive alcohol consumption. This HPLC study evaluated some clinical conditions and medications previously suggested to interfere with and cause non-alcohol related elevations of CDT." "Serum samples were collected from patients with end-stage liver disease (n=50), type 2 diabetes mellitus (n=46), cystic...
Source: Pharma Investments, Ventures & Law Weekly (2008-04-13)
|
